Cargando…

Fabrication of Stromal Cell-Derived Factor-1 Contained in Gelatin/Hyaluronate Copolymer Mixed with Hydroxyapatite for Use in Traumatic Bone Defects

Bone defects of orthopedic trauma remain a challenge in clinical practice. Regarding bone void fillers, besides the well-known osteoconductivity of most bone substitutes, osteoinductivity has also been gaining attention in recent years. It is known that stromal cell-derived factor-1 (SDF-1) can recr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Yun-Liang, Hsieh, Chia-Ying, Yeh, Chao-Yuan, Chang, Chih-Hao, Lin, Feng-Huei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306626/
https://www.ncbi.nlm.nih.gov/pubmed/34357232
http://dx.doi.org/10.3390/mi12070822
_version_ 1783727855734095872
author Chang, Yun-Liang
Hsieh, Chia-Ying
Yeh, Chao-Yuan
Chang, Chih-Hao
Lin, Feng-Huei
author_facet Chang, Yun-Liang
Hsieh, Chia-Ying
Yeh, Chao-Yuan
Chang, Chih-Hao
Lin, Feng-Huei
author_sort Chang, Yun-Liang
collection PubMed
description Bone defects of orthopedic trauma remain a challenge in clinical practice. Regarding bone void fillers, besides the well-known osteoconductivity of most bone substitutes, osteoinductivity has also been gaining attention in recent years. It is known that stromal cell-derived factor-1 (SDF-1) can recruit mesenchymal stem cells (MSCs) in certain circumstances, which may also play an important role in bone regeneration. In this study, we fabricated a gelatin/hyaluronate (Gel/HA) copolymer mixed with hydroxyapatite (HAP) and SDF-1 to try and enhance bone regeneration in a bone defect model. After material characterization, these Gel/HA–HAP and Gel/HA–HAP–SDF-1 composites were tested for their biocompatibility and ability to recruit MSCs in vitro. A femoral condyle bone defect model of rats was used for in vivo studies. For the assessment of bone healing, micro-CT analysis, second harmonic generation (SHG) imaging, and histology studies were performed. As a result, the Gel/HA–HAP composites showed no systemic toxicity to rats. Gel/HA–HAP composite groups both showed better bone generation compared with the control group in an animal study, and the composite with the SDF-1 group even showed a trend of faster bone growth compared with the composite without SDF-1 group. In conclusion, in the management of traumatic bone defects, Gel/HA–HAP–SDF-1 composites can be a feasible material for use as bone void fillers.
format Online
Article
Text
id pubmed-8306626
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83066262021-07-25 Fabrication of Stromal Cell-Derived Factor-1 Contained in Gelatin/Hyaluronate Copolymer Mixed with Hydroxyapatite for Use in Traumatic Bone Defects Chang, Yun-Liang Hsieh, Chia-Ying Yeh, Chao-Yuan Chang, Chih-Hao Lin, Feng-Huei Micromachines (Basel) Article Bone defects of orthopedic trauma remain a challenge in clinical practice. Regarding bone void fillers, besides the well-known osteoconductivity of most bone substitutes, osteoinductivity has also been gaining attention in recent years. It is known that stromal cell-derived factor-1 (SDF-1) can recruit mesenchymal stem cells (MSCs) in certain circumstances, which may also play an important role in bone regeneration. In this study, we fabricated a gelatin/hyaluronate (Gel/HA) copolymer mixed with hydroxyapatite (HAP) and SDF-1 to try and enhance bone regeneration in a bone defect model. After material characterization, these Gel/HA–HAP and Gel/HA–HAP–SDF-1 composites were tested for their biocompatibility and ability to recruit MSCs in vitro. A femoral condyle bone defect model of rats was used for in vivo studies. For the assessment of bone healing, micro-CT analysis, second harmonic generation (SHG) imaging, and histology studies were performed. As a result, the Gel/HA–HAP composites showed no systemic toxicity to rats. Gel/HA–HAP composite groups both showed better bone generation compared with the control group in an animal study, and the composite with the SDF-1 group even showed a trend of faster bone growth compared with the composite without SDF-1 group. In conclusion, in the management of traumatic bone defects, Gel/HA–HAP–SDF-1 composites can be a feasible material for use as bone void fillers. MDPI 2021-07-14 /pmc/articles/PMC8306626/ /pubmed/34357232 http://dx.doi.org/10.3390/mi12070822 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Chang, Yun-Liang
Hsieh, Chia-Ying
Yeh, Chao-Yuan
Chang, Chih-Hao
Lin, Feng-Huei
Fabrication of Stromal Cell-Derived Factor-1 Contained in Gelatin/Hyaluronate Copolymer Mixed with Hydroxyapatite for Use in Traumatic Bone Defects
title Fabrication of Stromal Cell-Derived Factor-1 Contained in Gelatin/Hyaluronate Copolymer Mixed with Hydroxyapatite for Use in Traumatic Bone Defects
title_full Fabrication of Stromal Cell-Derived Factor-1 Contained in Gelatin/Hyaluronate Copolymer Mixed with Hydroxyapatite for Use in Traumatic Bone Defects
title_fullStr Fabrication of Stromal Cell-Derived Factor-1 Contained in Gelatin/Hyaluronate Copolymer Mixed with Hydroxyapatite for Use in Traumatic Bone Defects
title_full_unstemmed Fabrication of Stromal Cell-Derived Factor-1 Contained in Gelatin/Hyaluronate Copolymer Mixed with Hydroxyapatite for Use in Traumatic Bone Defects
title_short Fabrication of Stromal Cell-Derived Factor-1 Contained in Gelatin/Hyaluronate Copolymer Mixed with Hydroxyapatite for Use in Traumatic Bone Defects
title_sort fabrication of stromal cell-derived factor-1 contained in gelatin/hyaluronate copolymer mixed with hydroxyapatite for use in traumatic bone defects
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306626/
https://www.ncbi.nlm.nih.gov/pubmed/34357232
http://dx.doi.org/10.3390/mi12070822
work_keys_str_mv AT changyunliang fabricationofstromalcellderivedfactor1containedingelatinhyaluronatecopolymermixedwithhydroxyapatiteforuseintraumaticbonedefects
AT hsiehchiaying fabricationofstromalcellderivedfactor1containedingelatinhyaluronatecopolymermixedwithhydroxyapatiteforuseintraumaticbonedefects
AT yehchaoyuan fabricationofstromalcellderivedfactor1containedingelatinhyaluronatecopolymermixedwithhydroxyapatiteforuseintraumaticbonedefects
AT changchihhao fabricationofstromalcellderivedfactor1containedingelatinhyaluronatecopolymermixedwithhydroxyapatiteforuseintraumaticbonedefects
AT linfenghuei fabricationofstromalcellderivedfactor1containedingelatinhyaluronatecopolymermixedwithhydroxyapatiteforuseintraumaticbonedefects